Kato, Masaru http://orcid.org/0000-0002-2023-6585
Hattori, Toshiyuki
Shimizu, Tomohiro
Ninagawa, Keita
Izumihara, Rimi
Nomoto, Hiroshi
Tanimura, Kazuhide
Atsumi, Tatsuya
Article History
Received: 18 April 2020
Accepted: 30 July 2020
First Online: 8 August 2020
Compliance with ethical standards
:
: Masaru Kato has received research grants from AbbVie, Actelion, and GlaxoSmithKline and speaking fees from Eli Lilly. Tatsuya Atsumi has received research grants from Astellas, Takeda, Mitsubishi Tanabe, Chugai, Daiichi-Sankyo, Otsuka, Pfize, Alexion, Bayer, Otsuka, Chugai, Takeda, Eisai, Bristol-Myers Squibb, Daiichi Sankyo, Mitsubishi Tanabe and AsahiKasei, consultant fees from Ono, Sanofi, Daiichi Sankyo and Pfizer and speaking fees from Mitsubishi Tanabe, Chugai, Astellas, Takeda, Pfizer, Daiichi Sankyo, Bristol-Myers Squibb and Eli Lilly. Other authors have nothing to declare.